Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: Campaigning in the early caucus state of Nevada, the 78-year-old Vermont senator said one of the things that disturbed him about Thursday's debate was that he was hoping "to have a serious discussion about the health care crisis in America." "I was not pleased that Vice President Biden distorted what Medicare for All is and, in fact, simply parroted the line coming from the health care industry," Sanders told about 300 people at a town hall meeting at the Carson City Community Center gymnasium. "Apparently the vice president thinks it is just wonderful for people to be paying $1,000 a month ... just for health care premiums. Having deductibles of $4,000 or $5,000 or more not a problem. Paying the highest prices in the world for prescription drugs not a problem. Well, I think those are problems," he said. Sanders took heavy fire on his single-payer health insurance proposal at Thursday night's debate in Houston, with Biden and others hammering the Vermont senator for the cost and the political palatability of effectively eliminating the existing private insurance market. The former vice president went hardest at Sanders when the senator argued that the estimated $30 trillion cost over a decade is cheaper than the "status quo," which he put at $50 trillion with most of the money being what Americans spend privately on premiums, copays and out-of-pocket costs. Sanders' argument is that most U.S. households would pay less overall under his system, even if their taxes go up. Biden said that Sanders would effectively be handing Americans a pay cut, arguing that employers who now pay a share of workers' premiums would pocket that money instead of giving workers raises if the government were to cover all health care costs. Biden punctuated the point with one of the quotes of the night: "For a socialist, you've got a lot more confidence in corporate America than I do." Biden has aggressively defended the Affordable Care Act that was created while he was vice president under President Barack Obama. Biden released a proposal in July to add a "public option" to the 2010 health care overhaul, with expanded coverage paid for by tax increases on the wealthiest Americans. Sanders repeated his refrain Friday that health care is a human right and that Medicare for All would cover every man, woman and child in the country. It requires no premiums, no deductibles and no out-of-pocket costs and would expand Medicare to include such things as dental care, hearing aids and home health care, he said. "It's not a terribly radical idea because in one form or another it exists in countries all over the world, including Canada," Sanders said. "Is it free? No. It is funded out of the general fund in a progressive manner." Sanders said the primary function of the existing American health care system the costliest in the world is to make profits for drug and insurance companies. Sanders and a supporter of President Donald Trump who said he recently lost his insurance and job initially shouted over each other when Sanders asked for input from the audience. But they eventually put their arms around each other as Sanders asked him to help deliver the message to health care corporations and pharmaceutical drug companies that "the function of health care is to provide quality care to all of these people." Sanders dismissed others who suggested Medicare for All would prevent people from selecting their own doctor. "You can go to any doctor you want," Sanders said. "Anybody who tells you Medicare for All limits your choices of doctors are not telling you the truth." Sanders lost the 2016 Democratic caucuses in Nevada to Hillary Clinton 55% to 45% primarily because of her strength in Las Vegas and Clark County but has maintained fierce support in the key Western swing state. He carried northern Nevada's Washoe County, where he drew loud cheers later Friday from hundreds of students at an outdoor "College For All" rally on the campus of the University of Nevada, Reno. He also planned to campaign Saturday in Las Vegas.

A: Sanders accuses Biden of distorting 'Medicare for All' plan.
****
Q: The use of eDNA sampling is already well established as a tool for monitoring marine life like whales and sharks. Whenever a creature moves through its environment, it leaves behind tiny fragments of DNA from skin, scales, feathers, fur, faeces and urine. "This DNA can be captured, sequenced and then used to identify that creature by comparing the sequence obtained to large databases of known genetic sequences from hundreds of thousands of different organisms," said team spokesman Professor Neil Gemmell of the University of Otago in New Zealand. The first written record of a monster relates to the Irish monk St Columba, who is said to have banished a "water beast" to the depths of the River Ness in the 6th century. The most famous picture of Nessie, known as the "surgeon's photo", was taken in 1934 and showed a head on a long neck emerging from the water. It was revealed 60 years later to have been a hoax that used a sea monster model attached to a toy submarine. Countless unsuccessful attempts to track down the monster have been made in the years since, notably in 2003 when the BBC funded an extensive scientific search that used 600 sonar beams and satellite tracking to sweep the full length of the loch. The most recent attempt was two years ago when a high-tech marine drone found a monster - but not the one it was looking for. The discovery turned out to be replica used in the 1970 film "The Private Life of Sherlock Holmes", which sank nearly 50 years ago. Gemmell's team, which comprises scientists from Britain, Denmark, the United States, Australia and France, is keen to stress the expedition is more than just a monster hunt. "While the prospect of looking for evidence of the Loch Ness monster is the hook to this project, there is an extraordinary amount of new knowledge that we will gain from the work about organisms that inhabit Loch Ness," Gemmell said on his university website. He predicts they will document new species of life, particularly bacteria, and will provide important data on the extent of several new invasive species recently seen in the loch, such as Pacific pink salmon. Their findings are expected to be presented in January 2019.

A: Scientists plan DNA hunt for Loch Ness monster next month.
****
Q: The story does a good job of describing the monthly cost ($850) for women who do not have health insurance. The inference is that insurers will cover the cost for others. The story needed to include more information about the study resultsin particular, how both the drug and the placebo performed in the trials. As we learn from the NEJM study, the drug reduced pain for about half of the women who took itbut the placebo also reduced pain for about 35% of the women who took it. That's a good detail to include as it provides a better sense of the drug's effectiveness. The text does an impressive job of sharing information about the debits of the drug, including bone loss and symptoms of menopause. The double-blind, placebo-controlled trials are described, as are cautions, such as the short-term nature of the research. The reader will find ample information about the unpleasant symptoms of endometriosis. In some areas, it comes close to disease-mongering, when pointing out very rare instances of women needing many surgeries, or a case study of one woman having endometrial tissue in her nose. However, endometriosis is a medical condition, and often under-diagnosed, so we'll rate this satisfactory. The scientist who led the two trials is clearly identified as such, but his consulting relationship with the company now marketing the drug is not mentioned, nor is the fact that that company, now positioned to benefit from selling the drug, paid for the studies. A number of existing pain-reduction alternatives are mentioned, from hormonal treatments to surgery, and their debits discussed. It would have been helpful to try and articulate how many women find the current alternatives insufficient. The text offers a likely date when this just-approved drug would become available at pharmacies. Although the research report describing the trials was published in The New England Journal of Medicinemore than a year ago, this story is pegged to a more useful (to readers) "new event," the US Food and Drug Administration's approval of the drug. Abbvie, the company that funded the Stage 3 clinical trials of elagolix (brand name: Orilissa) and will now market the drug, made available an extensive news release on its web site. The Vox story contains a good bit of enterprise reporting and produced a story that is far more clear than the company's effort.

A:
Women with endometriosis experience terrible pain. There's finally a new treatment.
****